ATA202886A - Verfahren zur herstellung eines kristallinen dimethylformamidsolvats der 7-((d)-2-amino2-(4-hydroxyphenyl)-acetamido)-3-((z)-1propenyl)-ceph-3-em-4-carbons|ure - Google Patents
Verfahren zur herstellung eines kristallinen dimethylformamidsolvats der 7-((d)-2-amino2-(4-hydroxyphenyl)-acetamido)-3-((z)-1propenyl)-ceph-3-em-4-carbons|ureInfo
- Publication number
- ATA202886A ATA202886A AT0202886A AT202886A ATA202886A AT A202886 A ATA202886 A AT A202886A AT 0202886 A AT0202886 A AT 0202886A AT 202886 A AT202886 A AT 202886A AT A202886 A ATA202886 A AT A202886A
- Authority
- AT
- Austria
- Prior art keywords
- 1propenyl
- amino2
- ceph
- acetamido
- ure
- Prior art date
Links
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 title 3
- -1 (D) -2-AMINO2- (4-HYDROXYPHENYL) -ACETAMIDO Chemical class 0.000 title 1
- 238000004519 manufacturing process Methods 0.000 title 1
- 239000012453 solvate Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
- C07D501/14—Compounds having a nitrogen atom directly attached in position 7
- C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
- C07D501/18—7-Aminocephalosporanic or substituted 7-aminocephalosporanic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
- A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
- C07D501/14—Compounds having a nitrogen atom directly attached in position 7
- C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
- C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
- C07D501/22—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with radicals containing only hydrogen and carbon atoms, attached in position 3
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Cephalosporin Compounds (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US06/759,805 US4694079A (en) | 1985-07-29 | 1985-07-29 | 3-propenyl cephalosporin solvates |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| ATA202886A true ATA202886A (de) | 1989-07-15 |
| AT389876B AT389876B (de) | 1990-02-12 |
Family
ID=25057020
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT0202886A AT389876B (de) | 1985-07-29 | 1986-07-28 | Verfahren zur herstellung eines kristallinen dimethylformamidsolvats der 7-((d)-2-amino2-(4-hydroxyphenyl)-acetamido)-3-((z)-1propenyl)-ceph-3-em-4-carbons|ure |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US4694079A (de) |
| KR (1) | KR930004014B1 (de) |
| CN (1) | CN1015263B (de) |
| AR (1) | AR243530A1 (de) |
| AT (1) | AT389876B (de) |
| CA (1) | CA1262345A (de) |
| CS (1) | CS258143B2 (de) |
| DD (1) | DD248594A5 (de) |
| EG (1) | EG18112A (de) |
| ES (1) | ES2001338A6 (de) |
| FI (1) | FI84269C (de) |
| GR (1) | GR861988B (de) |
| HU (1) | HU195224B (de) |
| NO (1) | NO167461C (de) |
| PT (1) | PT83074B (de) |
| SU (1) | SU1414317A3 (de) |
| YU (1) | YU45350B (de) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5128336A (en) * | 1988-03-23 | 1992-07-07 | Eli Lilly And Company | 3-(substituted)-1-carba(dethia)-3-cephems |
| DK0630380T3 (da) * | 1992-02-05 | 2001-12-10 | Biochemie Gmbh | Fremgangsmåde til rensning af et 3-cephem-4-carboxylsyrederivat |
| AT399876B (de) * | 1992-02-05 | 1995-08-25 | Biochemie Gmbh | Verfahren zur abreicherung von 7-amino-3-((e)-1- propen-1-yl)-3-cephem-4-carbonsäure |
| PT102061B (pt) * | 1997-10-08 | 2000-06-30 | J K Ind Ltd | Processo de preparacao de um antibiotico cefalosporina geralmente activo-cefixime |
| WO2001023393A1 (en) * | 1999-09-30 | 2001-04-05 | Otsuka Kagaku Kabushiki Kaisha | 3-cephem derivative crystal and method for preparing the same |
| KR100408430B1 (ko) * | 2001-04-18 | 2003-12-06 | 한미약품 주식회사 | 3-(z)-프로페닐 세펨 화합물의 선택적인 제조 방법 |
| US6903211B2 (en) * | 2002-10-30 | 2005-06-07 | Orchid Chemicals & Pharmaceuticals Limited | Process for the preparation of 3-propenyl cephalosporin DMF solvate |
| US7230097B2 (en) * | 2003-03-10 | 2007-06-12 | Lupin Ltd. | Process for preparation of 7-[α-Amino (4-hydroxyphenyl) acetamido]-3-substituted-3-cephem-4-carboxylic acid |
| WO2004110399A2 (en) * | 2003-06-19 | 2004-12-23 | Ranbaxy Laboratories Limited | Solvates of cefprozil |
| KR100576336B1 (ko) * | 2003-10-30 | 2006-05-03 | 씨제이 주식회사 | 세팔로스포린 유도체의 제조방법 |
| US20070072945A1 (en) * | 2004-03-31 | 2007-03-29 | Pohoreski Anton | Sulphur-containing oils for controlling plant pathogens and stimulating nutrient uptake |
| ES2338335T3 (es) | 2004-11-01 | 2010-05-06 | Hetero Drugs Limited | Nuevo procedimiento de preparacion de intermedio cefprozilo. |
| CN101058584B (zh) * | 2007-05-23 | 2010-05-26 | 上海骏捷生化科技有限公司 | 一种制备头孢丙烯母核7-氨基-3-丙烯基头孢烷酸的方法 |
| CN103524533B (zh) * | 2013-10-10 | 2016-01-27 | 珠海金鸿药业股份有限公司 | 一种头孢丙烯化合物、其分散片、干混悬剂及制备方法 |
| CN108017658B (zh) * | 2017-12-26 | 2020-06-16 | 山东裕欣药业有限公司 | 一种头孢丙烯的合成方法 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3985741A (en) * | 1972-09-15 | 1976-10-12 | Bristol-Myers Company | Production of p-hydroxycephalexin |
| EP0113568B1 (de) * | 1982-12-27 | 1990-04-04 | Eli Lilly And Company | Zwischenverbindungen für die Herstellung von Ceftazidin und Verfahren zu ihrer Herstellung |
| US4520022A (en) * | 1983-01-28 | 1985-05-28 | Bristol-Myers Company | Substituted vinyl cephalosporins |
-
1985
- 1985-07-29 US US06/759,805 patent/US4694079A/en not_active Expired - Lifetime
-
1986
- 1986-07-21 CA CA000514230A patent/CA1262345A/en not_active Expired
- 1986-07-22 YU YU1310/86A patent/YU45350B/xx unknown
- 1986-07-24 CS CS865613A patent/CS258143B2/cs not_active IP Right Cessation
- 1986-07-24 NO NO862970A patent/NO167461C/no not_active IP Right Cessation
- 1986-07-24 AR AR86304607A patent/AR243530A1/es active
- 1986-07-25 FI FI863066A patent/FI84269C/fi not_active IP Right Cessation
- 1986-07-25 SU SU864027831A patent/SU1414317A3/ru active
- 1986-07-27 EG EG469/86A patent/EG18112A/xx active
- 1986-07-28 PT PT83074A patent/PT83074B/pt unknown
- 1986-07-28 DD DD86292944A patent/DD248594A5/de unknown
- 1986-07-28 CN CN86105568A patent/CN1015263B/zh not_active Expired
- 1986-07-28 KR KR1019860006132A patent/KR930004014B1/ko not_active Expired - Lifetime
- 1986-07-28 AT AT0202886A patent/AT389876B/de not_active IP Right Cessation
- 1986-07-28 ES ES8600633A patent/ES2001338A6/es not_active Expired
- 1986-07-29 HU HU863230A patent/HU195224B/hu unknown
- 1986-07-29 GR GR861988A patent/GR861988B/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| PT83074A (en) | 1986-08-01 |
| GR861988B (en) | 1986-12-22 |
| CN86105568A (zh) | 1987-04-01 |
| KR930004014B1 (ko) | 1993-05-19 |
| YU131086A (en) | 1987-10-31 |
| HUT41799A (en) | 1987-05-28 |
| YU45350B (en) | 1992-05-28 |
| AR243530A1 (es) | 1993-08-31 |
| NO862970L (no) | 1987-01-30 |
| NO167461C (no) | 1991-11-06 |
| DD248594A5 (de) | 1987-08-12 |
| NO862970D0 (no) | 1986-07-24 |
| SU1414317A3 (ru) | 1988-07-30 |
| FI84269B (fi) | 1991-07-31 |
| CS258143B2 (en) | 1988-07-15 |
| NO167461B (no) | 1991-07-29 |
| ES2001338A6 (es) | 1988-05-16 |
| PT83074B (pt) | 1989-06-30 |
| FI863066A0 (fi) | 1986-07-25 |
| CS561386A2 (en) | 1987-09-17 |
| EG18112A (en) | 1992-08-30 |
| CA1262345A (en) | 1989-10-17 |
| AT389876B (de) | 1990-02-12 |
| CN1015263B (zh) | 1992-01-01 |
| KR870001216A (ko) | 1987-03-12 |
| FI863066L (fi) | 1987-01-30 |
| US4694079A (en) | 1987-09-15 |
| FI84269C (fi) | 1991-11-11 |
| HU195224B (en) | 1988-04-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AT377257B (de) | Verfahren zur herstellung neuer thiadiazolderivate | |
| ATA202886A (de) | Verfahren zur herstellung eines kristallinen dimethylformamidsolvats der 7-((d)-2-amino2-(4-hydroxyphenyl)-acetamido)-3-((z)-1propenyl)-ceph-3-em-4-carbons|ure | |
| DE3855137D1 (de) | Verfahren zur Herstellung eines Oxyd-Supraleiters | |
| AT383596B (de) | Verfahren zur herstellung von neuen thiazolidin-derivaten | |
| AT383351B (de) | Verfahren zur herstellung der neuen 7beta-(d-2amino-(p-hydroxyphenyl)-acetamido)-3-((z)-1propen-1-yl)-3-cephem-4-carbonsaeure | |
| AT381115B (de) | Verfahren zur herstellung kathodisch abscheidbarer lackbindemittel | |
| DE3889398D1 (de) | Verfahren zur Herstellung eines Supraleiters. | |
| AT386412B (de) | Verfahren zur herstellung eines cephalosporins | |
| ATA337185A (de) | Verfahren zur herstellung neuer flavolignanderivate | |
| ATA124285A (de) | Verfahren zur herstellung neuer iminothiazolidinderivate | |
| ATA444982A (de) | Verfahren zur herstellung neuer bisindolalkaloidderivate | |
| AT379936B (de) | Verfahren zur herstellung eines muerbteiges | |
| ATA192686A (de) | Verfahren zur herstellung der neuen 7-(3-chlorhu8507162725/8 | |
| ATA371584A (de) | Verfahren zur herstellung neuer cephalosporanderivate | |
| PT75749B (de) | Verfahren zur herstellung neuer phenol-derivate | |
| AT381097B (de) | Verfahren zur herstellung neuer thiazolintriazinderivate | |
| AT378185B (de) | Verfahren zur herstellung eines neuen cimetidin-monohydrats | |
| ATA86285A (de) | Verfahren zur herstellung neuer thiazolderivate | |
| PT74359A (de) | Verfahren zur herstellung neuer clavam-derivate | |
| AT386207B (de) | Verfahren zur herstellung eines cephalosporins | |
| AT379148B (de) | Verfahren zur herstellung heterocyclischer essigsaeure-derivate | |
| ATA229985A (de) | Verfahren zur herstellung neuer carbonsaeure-amido-thiolcarbamat-derivate | |
| AT388558B (de) | Verfahren zur herstellung neuer pyranoderivate | |
| ATA151286A (de) | Verfahren zur herstellung neuer benzthiazolderivate | |
| ATA554180A (de) | Verfahren zur herstellung von cephalosporansaeure- derivaten |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| ELA | Expired due to lapse of time |